Biotech2050 Podcast is a think tank chronicling the disruptions changing the biotech industry over the next 50 years.
…
continue reading
The Biotech Startups Podcast by Excedr features weekly conversations with founders, scientists, and investors driving biotech innovation. Host Jon Chee dives into the challenges of building biotech startups, from pre-seed to IPO. New episodes every Monday and Thursday.
…
continue reading
Burma | Chicago Scientist 🥼🧪🔬 Covering companies shaping healthcare 🏥 Stream new episodes, available on all podcast platforms!
…
continue reading
WTR Biotech Spotlight is a biweekly conversation with biotech executives, medical experts, and investors on recent clinical data or industry-driving events in biotech.
…
continue reading
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is p ...
…
continue reading
Inside Biotech is an exciting podcast from BCLA, which focuses on the science behind SoCal’s most innovative new biotech companies. This semi-monthly podcast, hosted by Gabriella Rubert, Ph.D. Candidate at UCLA and Podcast Lead at BCLA, is the perfect way for anyone interested in LA’s biotech community to stay informed about current progress and developments. Episodes feature conversations with scientists, entrepreneurs, investors, and more about the cutting-edge science that goes on inside ...
…
continue reading
This podcast aims to bring you a daily summary of the most relevant news in Pharma and BioTech. Check our website at: https://www.buzzsprout.com/2189790
…
continue reading
Between the Biotech Waves—discussing recent developments and market dynamics impacting the biotech sector.
…
continue reading
Welcome to BIOTECH NATION !!! With understandable interviews requiring no background in science, BTN attracts a wide global audience. From everyday people looking for hope in treatments in development, to bioentrepreneurs interested in the experience of their fellow travelers, to venture capitalists looking for possibilities in cutting-edge breakthroughs, to scientists simply interested in the work of others, BioTech Nation is the voice of human endeavor, driving science to new realities for ...
…
continue reading
Grow Everything reveals the world of biology as technology. Hosts Erum Khan and Karl Schmieder interview leaders and influencers biologizing industries with tools like synthetic biology, precision fermentation, bioprospecting, and more. These companies make biomaterials from waste, cosmetics that restore healthy hair and skin, and delicious cultivated foods in a bioreactor and so much more. Join us as we discuss the latest and greatest across biotech, synbio, entrepreneurship, and culture an ...
…
continue reading
Talking Biotech is a weekly podcast that uncovers the stories, ideas and research of people at the frontier of biology and engineering. Each episode explores how science and technology will transform agriculture, protect the environment, and feed 10 billion people by 2050. Interviews are led by Dr. Kevin Folta, a professor of molecular biology and genomics.
…
continue reading
Welcome to the official Labiotech.eu podcast - Beyond Biotech! Each week, we talk about what's happening in the world of biotech, with news and interviews with experts from companies around the world. Join us as we cover the latest news, breakthroughs and innovations shaping the life sciences industry.A new podcast episode is available every Friday. The host is Dylan Kissane.
…
continue reading
Data in Biotech is a fortnightly podcast exploring how companies leverage data to drive innovation in life sciences. Every two weeks, Ross Katz, Principal and Data Science Lead at CorrDyn, sits down with an expert from the world of biotechnology to understand how they use data science to solve technical challenges, streamline operations, and further innovation in their business. You can learn more about CorrDyn - an enterprise data specialist that enables excellent companies to make smarter ...
…
continue reading
Are you fascinated by the power and potential of biotechnology? Do you want to learn about cutting-edge innovations that can address climate change? The Climate Biotech Podcast explores the most pressing problems at the intersection of climate and biology, and most importantly, how to solve them. Hosted by Dan Goodwin, a neuroscientist turned biotech enthusiast, the podcast features interviews with leading experts diving deep into topics like plant synthetic biology, mitochondrial engineerin ...
…
continue reading
Welcome to the Biotech Bytes podcast, where we sit down with Biotech and Pharma IT leaders to learn what's working in our industry. Steven Swan is the CEO of The Swan Group LLC. He has 20 years of experience working with companies and individuals to make long-term matches. Focusing on Information technology within the Biotech and Pharmaceutical industries has allowed The Swan Group to become a valued partner to many companies. Staying in constant contact with the marketplace and its trends a ...
…
continue reading

1
Israeli Technology Founders Speak: Conversations with Successful Israeli Hitech and Biotech Entrepreneurs
JMB Davis Ben-David International IP Law Firm
Podcast by JMB Davis Ben-David International IP Law Firm
…
continue reading
Forschungsthemen aus dem Bereich Biotechnologie und Verfahrenstechnik an der TUHH
…
continue reading
Biotech knowledge center
…
continue reading
Matt breaks down relevant biotech stocks, analyzing their data and determining if they are a good investment.
…
continue reading
Biotech—it's complicated. A successful product launch requires grit, determination, and clear direction. But let’s be real, the path to launch isn’t a straight one. There are curves, hard turns, and dead ends. Here’s the good news, you don’t have to navigate the complexities alone. Welcome to The Emerging Biotech Leader, where we help biotech leaders maximize the value of their therapeutics from clinical development to product launch.
…
continue reading
BioTech Nation Radio with Dr Moira Gunn
…
continue reading
Interviews with innovators at the intersections of science, data, and technology.
…
continue reading
Welcome to the biotech podcast where we talk to the leading scientists in the world about their work, their lives and fundamental questions concerning their field.
…
continue reading
In the Biotech Career Coach podcast, we share valuable insights and advice for job seekers and career-minded individuals in the biotechnology and life sciences industry. From resume tips to leadership strategies, this podcast will help you navigate your job search and succeed in your career. This podcast is a production of The Collaboratory Career Hub To join our Community or access great resources, visit www.library.collaboratorycareerhub.com
…
continue reading
Defination Uses Various processes in Tissue - culture
…
continue reading
Illuminating life science career opportunities outside of academia through the experiences of those who have been there before.
…
continue reading
A weekly audio digest of the most important news in drug development affecting the pharmaceutical and biotech industry
…
continue reading
In einer Podcast Folge wird jeweils ein Punkt einer Lernplaneinheit vorgestellt. Viele sind One-Taker meiner eigenen Biotech-Abi Vorbereitung :D Cover art photo provided by Annie Spratt on Unsplash: https://unsplash.com/@anniespratt
…
continue reading
Horizon 3 is a biotech fund which has been formed to help investors to have a real impact on a range of global health challenges through new bio technologies, aiming to de-risk the investment risks inherent in such a technical area.These podcasts are a series aimed at educating investors on the issues, risks and opportunities involved in investing ion the biotech sector.
…
continue reading
Biotechnology for Tomorrow
…
continue reading
The Biotech Futurist aims to foster deep understanding and discussion about exciting hot topics in biotech at the intersection with artificial intelligence and medicine, exploring CRISPR therapeutics, neuroscience, genetic diseases, interventional genomics, machine learning in biology, behavior, neuroscience, omics, cellular recording, liquid biopsy, oncology, longevity, and more. Your host Luca Fusar Bassini, PhD student at EPFL in Switzerland, interviews an expert guest every week.
…
continue reading
From the ground floor to the C-Suite, Building Biotechs offers a behind-the-scenes look into the strategy that goes into launching and scaling successful biotech and life science companies. We talk with biotech executives, founders, HR leaders, and culture builders to learn how they think about growing companies with intention, and discuss the valuable lessons they’ve learned along the way.
…
continue reading
A weekly live audience show featuring the people building and funding companies that are extending healthy human lifespan. Join us Thursdays on Clubhouse and check the show schedule on longevitybiotechshow.com Hosted by Nathan Cheng (founder @ Longevity Marketcap // Longevity List) and Robert Ziman (Cohen Lab).
…
continue reading

1
Smart Biotech Scientist | Master Bioprocess CMC Development, Biologics Manufacturing & Scale-up, Cell Culture Innovation
David Brühlmann - CMC Development Leader, Biotech C-level Advisor, Business Strategist
The Go-to Podcast for Biotech Scientists Who Want to Master Biopharma CMC Development and Biomanufacturing. **TOP 10 LIFE SCIENCES PODCAST** Are you ready to simplify bioprocess development and scale with confidence to reduce time to market? Are you feeling overwhelmed by the complexity and guesswork of biologics development and biomanufacturing? Do you wish you had more time to enjoy the beauty of science, without worrying about failing your cell culture process development and commercializ ...
…
continue reading
From sales to medical affairs, we will help you break into and navigate your career in the biopharma industry!
…
continue reading
Back of the Napkin is a podcast series from Bio-Techne that meets scientific pioneers. It goes beyond the publications to hear the untold stories from innovation corner, where ideas and discoveries are conceived.
…
continue reading
Explore the world of cloning, protein folding, genome mapping, and more with the most important researchers in the field. Although the show is no longer in production at TWiT, you can enjoy episodes from the TWiT Archives.
…
continue reading
Explore the world of cloning, protein folding, genome mapping, and more with the most important researchers in the field. Although the show is no longer in production at TWiT, you can enjoy episodes from the TWiT Archives.
…
continue reading
A podcast to share the tools, tips, tricks and routines of the best biotech executives in the industry in order to help develop the next generation of biotech leaders and expedite the launch of new therapies and transform the lives of patients' all over the world.
…
continue reading
In this podcast, entrepreneur and angel investor Flavio Rump discusses the biggest bottlenecks and the future of biotech by speaking with some of the sharpest, most innovative minds in biotechnology and related fields.
…
continue reading
What happens when robots, AI, and big data enter the hospital? Glenn Cohen (a professor and deputy dean at Harvard Law School) is unpacking that question in this exploration of biotechnology, ethics, medical law, and health care policy. Each week, he’ll interrogate a single technology – such as digital pills, AI-powered decision support algorithms, or digital health apps – through the lens of ethical concerns like informed consent, liability, and privacy.
…
continue reading
Interviews with the researchers, founders, and investors of the BioTech industry. An insiders look into what is going on in the world of BioTech, from curing aging to psychedelic therapy, we interview the game changers of the industry. The unsung hero's that are moving the industry forward in a significant way. The world is going to be a vastly different place in the next 10-20 years because of what's happening in the BioTech industry right now.Human civilization will move forward farther, f ...
…
continue reading

1
Treating spinal cord injuries with stem cells
33:48
33:48
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
33:48Spinal cord injuries impact millions of people worldwide and, unlike many chronic injuries, they usually arrive with no forewarning, impacting the young and old alike. Brian Culley is CEO of Lineage Cell Therapeutics and his company is now in the clinic with a stem cell therapy for spinal cord injuries. Learn why stem cells could be promising for t…
…
continue reading
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. The Department of Health and Human Services, led by Secretary Robert F. Kennedy Jr., has revealed intentions to reduce 10,000 positions and restructure departments. The appointment of vaccine critic David Geier to investig…
…
continue reading

1
🧬 Michael Paliotti - MilliporeSigma: Master Biotech Sales & Build High-Performance Teams (Part 4/4)
31:01
31:01
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
31:01🧬 The Biotech Startups Podcast is powered by Excedr—helping life science startups accelerate R&D and commercialization with founder-friendly equipment leasing. Skip the upfront costs, stay lean, and focus on breakthrough science. As a TBSP listener, you can get exclusive perks through Excedr’s partner network—special savings, promotions, and more. …
…
continue reading

1
140: Regulatory Secrets Revealed: Why Your CMC Strategy Could Make or Break Your Biotech Startup with Rivka Zaibel - Part 2
20:42
20:42
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
20:42Send us a text In this episode, we explore the important steps in preparing for regulatory meetings, address the dangers of cross-contamination in biotechnology facilities, and debunk common misconceptions that could derail your CMC development strategy. As the founder and president of ADRES - Advanced Regulatory Services Ltd., Rivka Zaibel brings …
…
continue reading

1
How to Align People, Process & Technology for Real Impact with Irina Dymarsky
42:13
42:13
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
42:13How to Align People, Process & Technology for Real Impact #digitaltransformation #aiinbiotech #businessstrategy Too often, companies jump into new technology without addressing the real challenges holding them back. The key to successful transformation isn’t just about the latest AI tools—it’s about aligning people, processes, and technology to cre…
…
continue reading

1
Reimagining Bone Marrow Transplants... Kevin Caldwell, Co-Founder & CEO, Ossium Health
13:29
13:29
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
13:29This week on BioTech Nation, Ossium Health co-founder and CEO Kevin Caldwell shares how their breakthrough approach is changing bone marrow transplants. By cryobanking marrow from organ donors, Ossium is reducing wait times, improving access, and preparing for future emergencies. With support from BARDA and promising clinical trial results, this ne…
…
continue reading
Send us a text In this episode of Petri Dish Perspectives: Biotech Unleashed, we explore the rise of AbbVie, a pharmaceutical giant that emerged from Abbott Laboratories in 2013 and quickly became a leader in immunology, oncology, and aesthetics. From its blockbuster drug Humira to major acquisitions like Pharmacyclics and Allergan, AbbVie has stra…
…
continue reading

1
Neil McFarlane, President & CEO of Zevra Therapeutics, on Leading Rare Disease Innovation
35:35
35:35
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
35:35Synopsis: In this episode of Biotech2050, host Rahul Chaturvedi sits down with Neil McFarlane, President and CEO of Zevra Therapeutics, to explore his unique leadership journey from military nurse to biotech executive. Neil shares reflections from his time at Genzyme and UCB, insights on running a rare disease-focused biotech, and the art of missio…
…
continue reading

1
BoB@JPM: Nima Farzan, Latigo Biotherapeutics
43:32
43:32
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
43:32We love to hear from our listeners. Send us a message. In this final installment of our episodes recorded and filmed on-site at the JP Morgan Healthcare Conference, Nima Farzan, CEO of Latigo Biotherapeutics, shares his company's mission to change the pain management paradigm by way of novel, non-opioid medications that target NAV 1.8 sodium channe…
…
continue reading

1
121. Skin Deep: 'Peeling' Back the Layers of Skin Microbiome Diversity with Fjor's Natalie Enslow
55:22
55:22
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
55:22Erum and Karl dive into the fascinating world of the skin microbiome with Natalie Enslow, CEO and co-founder of Fjor. Natalie shares her journey from marketing to biotech, explaining how her brand is revolutionizing skincare by embracing the power of beneficial bacteria. She discusses the importance of microbial diversity, the challenges of launchi…
…
continue reading

1
Unlocking Enzymes' Potential by Locking Them in Place with James Weltz
48:36
48:36
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
48:36What if we could harness nature's most precise chemical tools and make them work in industrial settings? James Weltz, co-founder and CSO of Cascade Bio, reveals how enzyme immobilization technology is transforming chemical manufacturing by stabilizing delicate biological catalysts. From his childhood exploring chemical plants with his industrial hy…
…
continue reading

1
How AI Can Increase Clinical Trial Efficiency with Patrick Leung from Faro Health
39:02
39:02
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
39:02How can AI improve clinical trials and accelerate drug development? In this episode of Data in Biotech, Ross Katz sits down with Patrick Leung, CTO of Faro Health, to explore how AI-driven tools are reshaping clinical trial design. Patrick shares insights into document generation, patient burden analysis, and AI governance in biotech. Learn how Far…
…
continue reading

1
Annovis Bio's CEO Discusses the promise of Buntanetap in Redefining the Treatment of Alzheimer's and Parkinson's and Next Steps
18:23
18:23
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
18:23Founding CEO and President of Annovis Bio (NYSE: ANVS) Dr Maria Maccecchini joins WTR's Tim Gerdeman and Robert Sassoon in this week's WTR Small-Cap Spotlight episode. Annovis is a late clinical-stage drug platform company developing novel disease-modifying therapies for neurodegenerative diseases, to include targeting Alzheimer's and Parkinson's, …
…
continue reading

1
Repurposing Drugs & Reinventing Biotech: Dr. Adam Watson on Building MeCo Diagnostics
59:52
59:52
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
59:52In this discussion, Dr. Adam Watson, Co-founder and CEO of MeCo Diagnostics, shares the personal and professional experiences that led him to focus on cancer research and, ultimately, to launch his own company. From the profound influence of his family’s battle with cancer to the long and complex journey of developing the MeCo Score™, he walks us t…
…
continue reading
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Today, we will discuss the upcoming challenge in the pharmaceutical industry of manufacturing oral GLP-1 medications, following previous issues with injectable GLP-1s. Companies like Eli Lilly and Novo Nordisk are competin…
…
continue reading
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.President Trump has nominated Susan Monarez as the new head of the CDC, facing challenges such as a measles outbreak that has already resulted in two deaths. Merck commits nearly $2 billion for an oral lipid-lowering drug…
…
continue reading
Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.AbbVie has filed a lawsuit against Genmab, alleging that they have unlawfully used trade secrets to advance the development of antibody-drug conjugates through a company they acquired. On another note, AstraZeneca has mad…
…
continue reading

1
139: Regulatory Secrets Revealed: Why Your CMC Strategy Could Make or Break Your Biotech Startup with Rivka Zaibel - Part 1
25:21
25:21
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
25:21Send us a text In biotherapeutic drug development, the journey from discovery to clinic involves navigating a labyrinth of regulatory requirements and strategic considerations, particularly in Chemistry, Manufacturing, and Control (CMC). In this episode of the Smart Biotech Scientist, host David Brühlmann engaged with Rivka Zaibel, President and Fo…
…
continue reading

1
🧬 Michael Paliotti: Blending Science, Sales, and Side Hustles in Biotech (Part 3/4)
41:59
41:59
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
41:59🧬 The Biotech Startups Podcast is powered by Excedr—helping life science startups accelerate R&D and commercialization with founder-friendly equipment leasing. Skip the upfront costs, stay lean, and focus on breakthrough science. As a TBSP listener, you can get exclusive perks through Excedr’s partner network—special savings, promotions, and more. …
…
continue reading

1
Pharma and Biotech Daily: FDA Approves Alnylam's Amvuttra for Rare Cardiovascular Disease, Sparking Competition with Pfizer and BridgeBio
1:53
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.The CDC has rescheduled a vaccine meeting for April, while President Trump is considering Texas Republican Michael Burgess as the new director of the agency. J&J's Tremfya has won approval for expansion in treating Crohn'…
…
continue reading

1
Are mitochondrial therapeutics about to go mainstream?
37:47
37:47
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
37:47Mitochondria are famously the powerhouse of the cell, but will mitochondrial therapeutics power the next big mainstream medical breakthrough? Klaus Dugi is CEO of Vandria, a biotech that develops mitophagy inducers that rejuvenate cells to treat age-related and chronic diseases. He joins 'Beyond Biotech' to talk cell mitophagy, biotech agility, and…
…
continue reading
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Sanofi has committed up to $1.9 billion to acquire Dren Bio's bispecific antibody for autoimmune disease, adding to its investments in the immunology portfolio. The deal comes after the tragic death of a patient who had ta…
…
continue reading

1
🧬 Michael Paliotti: Navigating Biotech Careers & Building Lasting Relationships (Part 2/4)
43:33
43:33
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
43:33"Success in this industry isn’t just about what you know—it’s about how you connect with people, bring value, and build lasting relationships." In part two of our conversation with Michael Paliotti, we delve into his journey from academic research to industry, and his eventual transition into sales within the biotech sector. Michael shares his expe…
…
continue reading
Send us a text Welcome to Petri Dish Perspectives: Biotech Unleashed! In this episode, we dive deep into the history and impact of Eli Lilly, a company that began with a small lab in Indianapolis and has grown into the highest market-cap pharmaceutical company in the world. From pioneering insulin production in the 1920s to developing blockbuster d…
…
continue reading
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Roche has made a $1 billion investment in Oxford Biotherapeutics to gain access to their antibody-drug conjugate platform for cancer targets. Cargo has laid off 90% of its staff and is exploring potential business combina…
…
continue reading

1
138: Skip 90% of Bioreactor Runs: The In Silico Revolution in Bioprocess Development with Yossi Quint - Part 2
20:16
20:16
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
20:16Send us a text In the fast-evolving world of biotechnology, the pursuit of efficiency and faster development has never been more critical. The computational tools and models currently being integrated into bioprocessing present a groundbreaking approach that promises radical shifts in drug development timelines and capabilities. In the second part …
…
continue reading

1
Raj Devraj, President & CEO - Rectify Pharma, on Drug Discovery, Biotech Breakthroughs & Growth
34:03
34:03
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
34:03Synopsis: How do you build a biotech company that disrupts drug discovery and delivers real impact? In this episode of Biotech 2050, host Rahul Chaturvedi speaks with Raj Devraj, President & CEO of Rectify Pharmaceuticals and Venture Partner at Atlas Venture.Raj shares his journey from big pharma to biotech entrepreneurship, the science behind Rect…
…
continue reading

1
When Your Immune System Attacks You... Prof. Dr. Niels Riedemann, Co-Founder & CEO, Inflarx
21:52
21:52
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
21:52This week on BioTech Nation, we explore what happens when your immune system overreacts. Professor Niels Riedemann, CEO of InflaRx, explains how the body’s defense system can sometimes cause more harm than good, leading to serious conditions like rheumatoid arthritis, severe COVID-19, and lung failure. Learn how InflaRx is developing treatments to …
…
continue reading
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.## Sarepta's DMD gene therapy patient dies, causing a 22% drop in shares.Sarepta experienced a significant setback as a patient participating in their DMD gene therapy trial tragically passed away, leading to a 22% decrea…
…
continue reading
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.AstraZeneca has recently made a significant investment of up to $1 billion in cell therapy through the acquisition of esobiotec. This move is part of AstraZeneca's larger strategy to expand in the cell therapy space, posi…
…
continue reading

1
137: Skip 90% of Bioreactor Runs: The In Silico Revolution in Bioprocess Development with Yossi Quint - Part 1
21:55
21:55
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
21:55Send us a text The integration of AI into drug discovery has already led to groundbreaking advancements, uncovering patterns in vast datasets that were previously invisible to human researchers. Now, AI is set to revolutionize bioprocessing as well. In this episode of the Smart Biotech Scientist Podcast, Yossi Quint, founder and CEO of Ark, and Dav…
…
continue reading

1
BoB@JPM: Kasper Roet, Ph.D., QurAlis
43:46
43:46
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
43:46We love to hear from our listeners. Send us a message. Dr. Kasper Roet's hands-on work at the Dutch Brain Bank informed his leadership at the biotech QurAlis, where three clinical programs targeting specific genetic mechanisms in ALS are now underway. On this episode of the Business of Biotech, Life Science Leader's Ben Comer joins to co-host a con…
…
continue reading

1
🧬 Michael Paliotti: Navigating a Winding Path to Biotech Success (Part 1/4)
41:06
41:06
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
41:06🧬 The Biotech Startups Podcast is powered by Excedr—helping life science startups accelerate R&D and commercialization with founder-friendly equipment leasing. Skip the upfront costs, stay lean, and focus on breakthrough science. As a TBSP listener, you get exclusive perks through Excedr’s partner network—special savings, promotions, and more. Expl…
…
continue reading
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Altimmune, a biopharmaceutical company based in Maryland, has announced plans to test an investigational drug based on GLP-1 for the treatment of alcohol use disorder. This drug is also being studied by Eli Lilly and Nov…
…
continue reading

1
120. Busting Biotech's Bottlenecks: Veronica Breckenridge on the Path to Industrial Scale
1:02:33
1:02:33
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
1:02:33Karl and Erum sit down with Veronica Breckenridge, founder of First Bight Ventures, to discuss how the convergence of biology and technology is driving the biggest innovations of the 21st century. Drawing from her deep tech background, including her time at Apple, Veronica explores rapid advancements in genome sequencing, AI-driven biotech, and the…
…
continue reading

1
Fighting Alzheimer's with innovative stem cell therapies
41:51
41:51
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
41:51Regeneration Biomedical has developed a new technique to address neurodegenerative diseases like Alzheimer's using stem cell therapy. Dr. Christopher Duma, has long been an innovator in neurosurgery using a gamma knife radiosurgery to treat glioblastoma. Now with Regeneration Biomedical, Duma is taking on neurodegenerative diseases with a first-in-…
…
continue reading
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.The Trump administration has withdrawn CDC nominee Dave Weldon at the last minute, while NIH and FDA picks advance. Acelyrin has implemented a poison pill strategy to prevent Tang Capital from acquiring the company. Johns…
…
continue reading

1
How to Grow Your Own Story with Erum Azeez Khan and Karl Schmieder
45:38
45:38
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
45:38What happens when brilliant scientific innovation meets masterful storytelling? Marketing rarely tops the priority list for scientists and biotech founders who are deep in the technical challenges of making their innovations work. Yet without effective communication, even groundbreaking discoveries risk languishing in obscurity, unable to attract t…
…
continue reading

1
🧬 Stavros Papadopoulos: Transforming Data Management (Part 4/4)
34:08
34:08
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
34:08🧬 The Biotech Startups Podcast is powered by Excedr—helping life science startups accelerate R&D and commercialization with founder-friendly equipment leasing. Skip the upfront costs, stay lean, and focus on breakthrough science. As a TBSP listener, you get exclusive perks through Excedr’s partner network—special savings, promotions, and more. Expl…
…
continue reading
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Bluebird bio has made the decision to go private in order to restructure and focus on long-term growth amidst declining valuations and funding challenges in the biotech industry. This move reflects a strategic shift in res…
…
continue reading

1
136: 5 Roadblocks to Affordable Biologics (And How to Overcome Them)
13:28
13:28
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
13:28Send us a text Sickle cell disease affects thousands with severe daily pain. While FDA-approved gene therapies exist, their $2.2 million cost per treatment makes them largely inaccessible. In this episode of the Smart Biotech Scientist Podcast, David Brühlmann explores five key challenges facing the bioprocessing industry in making these therapies …
…
continue reading
This week on BioTech Nation, Dr. Daniel Kraft explores how smarter design can make healthcare easier, less stressful, and more effective. From hospitals built for patient comfort to medical apps that adapt to your needs, the way we experience healthcare is evolving. Learn how design thinking and empathy are shaping the future of medicine.…
…
continue reading
Send us a text 💊 From Brooklyn to Biotech Titan: The Rise of Pfizer 💊 Welcome to the first-ever episode of Petri Dish Perspectives: Biotech Unleashed! 🚀 I’m your host, Manead—scientist, biotech nerd, and your guide through the fascinating world of life sciences. We’re kicking things off with Pfizer—a company that started as a small chemical busines…
…
continue reading
Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Bristol Myers Squibb (BMS) has acquired 2seventy, the partner of Abecma, for $286 million, ending their cost-sharing agreement. Abecma generated $406 million in 2024, with BMS paying $43 million to 2seventy as part of the…
…
continue reading

1
Pharma and Biotech Daily: Novo's Weight Loss Drug Disappointment and J&J's Psoriasis Breakthrough
1:57
Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Novo's next-generation weight loss drug, cagrisema, has disappointed once again with lower-than-expected weight loss results. The latest data showed only a 15.7% weight loss in patients with diabetes after 68 weeks, below…
…
continue reading

1
135: Beyond Breakthroughs: Making Biotherapeutics Affordable for All
12:46
12:46
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
12:46Send us a text In a world of rapid advancements in medical science and biotechnology, bioprocessing is at the forefront of healthcare innovation. Yet, despite remarkable progress, life-saving biotherapeutics remain out of reach for much of the global population. A staggering 80% of patients worldwide lack access to the biotherapeutics they need. Wh…
…
continue reading

1
Revolutionizing CAR T with CRISPR: Rachel Haurwitz, President & CEO of Caribou Biosciences
26:25
26:25
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
26:25Synopsis: Host Rahul Chaturvedi welcomes back Rachel Haurwitz, President & CEO of Caribou Biosciences, for a deep dive into the future of CRISPR-based genome editing and its transformative impact on cell therapy. As a pioneer in the field, Rachel shares the evolution of off-the-shelf CAR T therapies and how Caribou Biosciences is tackling some of t…
…
continue reading

1
BoB@JPM: Rick Modi, Affinia Therapeutics
52:20
52:20
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
52:20We love to hear from our listeners. Send us a message. The latest in our series of Business of Biotech podcasts recorded in-person at JPM in San Francisco features an inspiring conversation with Affinia Therapeutics CEO Rick Modi. Modi shares on how his upbringing in Kenya shaped his adversity-embracing worldview, and how that worldview contributes…
…
continue reading

1
🧬 Stavros Papadopoulos: Scaling TileDB & Revolutionizing Data Infrastructure (Part 3/4)
36:00
36:00
Lire Plus Tard
Lire Plus Tard
Des listes
J'aime
Aimé
36:00🧬 The Biotech Startups Podcast is powered by Excedr—helping life science startups accelerate R&D and commercialization with founder-friendly equipment leasing. Skip the upfront costs, stay lean, and focus on breakthrough science. As a TBSP listener, you get exclusive perks through Excedr’s partner network—special savings, promotions, and more. Expl…
…
continue reading
Good morning from Pharma and Biotech Daily, the podcast that gives you only what's important to hear in the Pharma and Biotech world. J&J has recently halted a late-stage depression trial due to lack of efficacy. Analysts do not believe this will have a significant impact on the company's broader neuroscience strategy. Meanwhile, there seems to be …
…
continue reading